Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain

Neuroscience Letters

Volumn 220, Issue 2, 1996, Pages 117-120

  Deffois, A ^a   Fage, D ^a   Carter, C ^a  

^a SANOFI   (France)

Author keywords

Analgesia; Antidepressants; Neuroleptics; Sodium channels; Synaptosomes

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LOCAL ANESTHETIC AGENT; NEUROLEPTIC AGENT; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; UNINDEXED DRUG; VERATRIDINE;

ANALGESIA; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CALCIUM CELL LEVEL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; RATS; SODIUM CHANNEL BLOCKERS; SYNAPTOSOMES; VERATRIDINE;

EID: 0030582763     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13227-4     Document Type: Article

References (20)

1. [1] Backonja, M.M., Local anaesthetics as adjuvant analgesics, J. Pain Sympt. Manag., 9 (1994) 491-499.
2. [2] Blier, P. and de Montigny, C., Current advances and trends in the treatment of depression, Trends Pharmacol. Sci., 15 (1994) 220-226.
3. [3] Bowsher, D., Pain syndromes and their treatment, Curr. Opin. Neurol. Neurosurg., 6 (1993) 257-263.
4. [4] Carter, C., Fage, D., Delatte, C. and Deffois, A., ω-Aga-and ω-conotoxin resistant calcium entry stimulated by 50 mM potassium or 10 μM veratridine in rat cortical synaptosomes, Am. Soc. Neurosci., 22 (1996) 690.2.
5. [5] Catterall, W.A., Common modes of drug action on Na + channels: local anaesthetics, antiarrhythmics and anticonvulsants, Trends Pharmacol. Sci., 8 (1987) 57-65.
6. [6] Cheung, H., Kamp, D. and Harris, E., An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels, Epilepsy Res., 13 (1992) 107-112.
7. [7] Dray, A., Urban, L. and Dickenson, A., Pharmacology of chronic pain. Trends Pharmacol. Sci., 15 (1994) 190-197.
8. [8] Eisenach, J.C. and Gebhart, G.F., Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats, Anesthesiology, 83 (1995) 1036-1045.
9. [9] Goa, K.L., Ross, S.R. and Chrisp, P., Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy, Drugs, 46 (1993) 152-176.
10. [10] Haugland, R.P., Molecular Probes: Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes Inc., Eugene, OR, 1992.
11. [11] Hebert, T., Drapeau, P., Pradier, L. and Dunn, R.J., Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole, Mol. Pharmacol., 45 (1994) 1055-1060.
12. [12] Hegarty, A. and Portenoy, R.K., Pharmacotherapy of neuropathic pain, Semin. Neurol., 14 (1994) 213-224.
13. [13] Kucharczyk, J., Mintorovitch, J., Moseley, M.E., Asgari, H.S., Sevick, R.J., Derugin, N. and Norman, D., Ischaemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476, Radiology, 179 (1991) 221-227.
14. [14] Kuo, C.C. and Bean. B.P., Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons, Mol. Pharmacol., 46 (1994) 716-725.
15. [15] McQuay, H., Carroll, D., Jadad, A., Wiffen, P. and Moore, A., Anticonvulsant drugs for management of pain: a systematic review, Br. Med. J., 311 (1995) 1047-1052.
16. [16] Ollat, H. and Cesaro, P., Pharmacology of neuropathic pain, Clin. Neuropharmacol., 18 (1995) 391-404.
17. [17] Reynolds, I.J. and Miller, R.J., Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc, Br. J. Pharmacol., 95 (1988) 95-102.
18. [18] Rogawski, M.A. and Porter, R.J., Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev., 42 (1990) 223-286.
19. [19] Tamargo, J., Valenzuela, C. and Delpon, E., New insights into the pharmacology of sodium channel blockers, Eur. Heart J., 13 (1992) 2-13.
20. + channels as targets for neuroprotective drugs, Trends Pharmacol. Sci., 16 (1995) 309-316.